---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-187977"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2022-07-05T23:59:59+00:00"
generated_at: "2026-06-24T21:26:39.659264+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Adagio names David Hering permanent CEO with $600K salary, 2M share option; board overhauled

## Summary
- David Hering, previously interim CEO and COO, appointed permanent CEO and director effective July 5, 2022.
- Hering receives $600K base salary, 60% target bonus, and initial option grant for 2,000,000 shares vesting over 48 months.
- Eligible for additional option grant of up to 1,000,000 shares if performance goals achieved by Dec 31, 2022.
- Annual meeting elects Tamsin Berry, Marc Elia, Clive Meanwell to board; Marc Elia appointed board chair.

## SEC filing metadata
- accession: 0001193125-22-187977
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2022-07-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312522187977/0001193125-22-187977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312522187977/d304609d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-187977
- JSON: https://secwatch.observer/filing/0001193125-22-187977.json
- Plain text: https://secwatch.observer/filing/0001193125-22-187977.txt

## Key facts
- Executive change
  David Hering was appointed as Chief Executive Officer and Director at Invivyd, Inc..
  - Action: appointed
  - Role: Chief Executive Officer and Director
  source text: On July 5, 2022 (the “Effective Date”), the Board of Directors (the “Board”) of Adagio Therapeutics, Inc. (the “Company”) appointed David Hering, M.B.A., age 47, as the Company’s Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832038/000119312522187977/0001193125-22-187977-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.